LIGAND PHARMACEUTICALS INCORPORATED Payments to Acquire Other Investments
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Payments to Acquire Other Investments of $1.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire other investments for fiscal 2025 was $3.85M, a 53.88% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire other investments for fiscal 2024 was $2.50M.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire other investments for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 12 month |
|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $3.85M 10-K · filed 2026-02-27 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $2.50M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |